home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  

registry of biomedical companies

  March 24, 2018
promoting the transfer of scientific know-how between industry and academia
Registry of biomedical companies:

[1] [3] [4] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 584 active entries

Abazyme, LLC

767C Concord Ave.
Cambridge, MA 02138
United States of America, Massachusetts
Toll free: 800 693 1418

Phone: 339-337-6227
Fax: 775-206-7905

Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.


Abazyme: Where Antibodies go Molecular...

 Abazyme LLC is a leading provider of custom recombinant monoclonal antibody (rMAb)services. 

Our proprietary ACE™ cloning process enables us to produce recombinant antibodies from either newly created or existing hybridomas.

  • Deliverables include antibody sequence, stable expression vectors as well as expressed antibody.
  • Modifications such as class-switching are possible with recombinant antibodies.
  • No need for nitrogen freezers, or cell-banking, vectors can be stored indefinitely in normal freezers.
  • Antibodies defined by sequence are more readily useful for regulatory filings.

Call us today to discuss your project needs. Our experts will work with you to design antibody projects that fit your needs.  

Selected Categories:
Product Company   Service Company
- Research
- Research
- Immunoassay
- Research
- Laboratory
- Research
- Services

Last update of this entry: July 16, 2014

home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 1995-2018 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.